期刊文献+

猪带绦虫TSOL18特异性单克隆抗体的制备及其体外杀虫作用的研究

Preparation of Anti-TSOL18 Monoclonal Antibodies and Their Effect on Taenia solium Oncospheres
下载PDF
导出
摘要 本研究目的在于制备抗猪带绦虫TSOL18单克隆抗体,并分析单抗对六钩蚴的杀伤作用。采用SephadexG-100纯化在毕赤酵母中表达的猪带绦虫六钩蚴TSOL18蛋白;纯化的蛋白免疫BALB/c小鼠,运用杂交瘤技术建立能分泌抗TSOL18单克隆抗体的细胞株;通过ELISA叠加试验进行mAb的抗原表位分析;采用间接ELISA法测定TSOL18单克隆抗体特异性及腹水效价;采用抗TSOL18单克隆抗体对激活的猪带绦虫六钩蚴进行体外六钩蚴杀伤试验,观察单抗对猪带绦虫六钩蚴活力的影响。结果成功获得12株稳定分泌抗TSOL18单克隆抗体的杂交瘤细胞株,识别2个不同抗原表位,不同抗原表位的2株单克隆抗体腹水效价分别为1×102、1×106。抗体体外六钩蚴杀伤试验结果证明,在有补体的情况下,多抗和单抗作用6 d后,六钩蚴结构模糊,边缘不清晰。表明单抗对六钩蚴有一定的杀伤作用。 MAbs against Taenia solium TSOL18 were prepared and their in vitro effect on oncospheres was analyzed.TSOL18 expressed in Pichia pastoris was purified with Sephadex G-100;mAbs were prepared by hybridoma technique using purified TSOL18 as an immunogen;Antigen epitopes were tested by ELISA adding test;Specificity and titer of the mAbs was determined using indirect ELISA;The effect of the mAbs on oncospheres was tested by in vitro oncospheres-killing test.Twelve hybridoma cell lines were obtained stably secreting TSOL18 mAbs,and two different recognized epitopes were identified.Their antibody titers were 10^2 and 10^6 in the ascites,respectively,and two of monoclonal antibodies interacted with the TSOL18 specifically.In vitro oncospheres-killing test showed that the structure and margin of the oncospheres are vague after treating with antibody and complements for six days.Results proved that the TSOL18 mAbs have some killing effect on T.solium oncospheres.
出处 《畜牧兽医学报》 CAS CSCD 北大核心 2010年第2期208-213,共6页 ACTA VETERINARIA ET ZOOTECHNICA SINICA
基金 国家“863”计划项目(2006AA10A207) 国家科技支撑计划项目(2007BAD40B03) 家畜疫病病原生物学国家重点实验室项目(SKLVEB2008ZZKT013) 基本科研业务费专项资金项目(BRF070308)
关键词 猪带绦虫六钩蚴 TSOL18 单抗 体外杀六钩蚴作用 Taenia solium oncosphere TSOL18 mAb in vitro oncosphere-killing assay
  • 相关文献

参考文献24

  • 1RAJSHEKHAR V, JOSHI D D, DOANH N Q, et al. Taenia solium/taeniosis cysticercosis in Asia: epidemiology, impact and issues[J]. Acta Trop, 2003, 87(1) : 53-60.
  • 2SCIUTTO E, FRAGOSO G, FLEURY A, et al. Taenia soliurn disease in humans and pigs., an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions[J]. Microbes Infect, 2000, 2(15) : 1875-1890.
  • 3FLISSER A, GAUCI C G, ZOLI A, et al. Induction of proteetion against porcine cysticereosis by vaecination with recombinant oncosphere antigens[J]. Infect Immun, 2004, 72(9): 5292-5297.
  • 4CAI X, YUAN G, ZHENG Y, et al. Effective pro- duction and purification of the glycosylated TSOL18 antigen, which is protective against pig eysticercosis [J]. Infect Immun, 2008, 76(2): 767-770.
  • 5GAUCI C G, ITO A, LIGHTOWLERS M W. Conservation of the vaccine antigen gene, TSOL18, among genetically variant isolates of Taenia solium [J]. Mol Biochem Parasitol, 2006, 146(1): 101- 104.
  • 6CHEN H T. The in vitro action of rat immune serum on the larvae of Taenia taeniaeformis [J]. Journal of Infectious Diseases, 1950, 86(3) : 205-213.
  • 7SILVERMAN P H. A technique for studying 1:he in vitro effect of serum on activated Taeniid he:racanth embryos[J].Nature, 1955, 176: 598-599.
  • 8HEATH D D, SMYTH J D. In vitro cultivation of Echinococcus granulosus, Taenia hydatigena , T. ovis, T. pisiformis and T. serialis from oncosphere to cystic larva[J]. Parasitology, 1970, 61(3): 329- 343.
  • 9RICKARD M D, OUTTERIDGE P M. Antibody and cell mediated immunity in rabbits infected with the larval stages of Taenia pisiformis [J]. Parasitol Res, 1974, 44(3): 187-201.
  • 10HEATH D D, PAVLOFF P. The fate of Taenia taeniaeformis oncospheres in normal and passively protected rats[J]. Int J Parasitol, 1975, 5(1): 83-88.

二级参考文献9

  • 1John GB. Antibiotic-associated diarrhea[J]. Clin Infect Dis, 1992, 15: 573-581.
  • 2John GB. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism[J]. Clin Infect Dis, 1994, 18: S265-272.
  • 3Eichel-Streiber CV, Harperath U, Boss D, et al. Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related[J]. Microbiol Path, 1987, 2: 307-318.
  • 4Sullivan NM, Pellet S, Wilkins TD. Purification and characterization of toxins A and B of Clostridium difficile[J]. Infect Immun, 1982, 35: 1032-1040.
  • 5Meng XQ, Kamiya S, Yamakawa K, et al. Purification and characterization of intracellular toxin A of Clostridium difficile[J]. J Med Microbiol, 1993, 38: 69-73.
  • 6Friguet B, Diavadi O, Pages J, et al. A convenient enzyme-linked-immunosorbent assay for testing whether monoclonal antibodies recognize the same antigenic site and application to hybridomes specific for the β 2-subunit of Escherichia coli tryptophan syn
  • 7Kamiya S, Yamakawa K, Meng XQ, et al. Production of monoclonal antibody to Clostridium difficile toxin A which neutralises enterotoxicity but not haemagglutination activity[J]. FEMS Microbiol Letters, 1991, 81: 311-316.
  • 8Dove CH,Wang SZ,Price SB,et al.Molecular characterization of the Clostridium difficile toxin A gene[J].Infect Immun,1990,58:480-488.
  • 9姚敏捷,黄汉朝,攸连秀.抗人层黏连蛋白单克隆抗体的制备及特性鉴定[J].细胞与分子免疫学杂志,2003,19(1):84-85. 被引量:5

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部